RDA Financial Network lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 35.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 6,821 shares of the medical equipment provider’s stock after selling 3,748 shares during the period. Intuitive Surgical accounts for approximately 0.9% of RDA Financial Network’s portfolio, making the stock its 22nd biggest position. RDA Financial Network’s holdings in Intuitive Surgical were worth $3,863,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. increased its position in Intuitive Surgical by 0.8% during the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after purchasing an additional 263,828 shares during the last quarter. State Street Corp grew its stake in shares of Intuitive Surgical by 1.2% in the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after buying an additional 182,871 shares during the period. Capital World Investors increased its holdings in shares of Intuitive Surgical by 1.5% during the 3rd quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock worth $3,456,223,000 after buying an additional 116,034 shares during the last quarter. Norges Bank purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at approximately $2,569,260,000. Finally, Invesco Ltd. lifted its holdings in Intuitive Surgical by 4.8% in the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock valued at $2,402,488,000 after acquiring an additional 201,159 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Price Performance
Shares of Intuitive Surgical stock opened at $479.93 on Friday. The stock has a market capitalization of $170.44 billion, a price-to-earnings ratio of 60.83, a price-to-earnings-growth ratio of 3.68 and a beta of 1.66. The business has a 50-day moving average of $505.00 and a 200 day moving average of $512.62. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $603.88.
Key Headlines Impacting Intuitive Surgical
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Analyst bullishness highlights ISRG as a growth play, reinforcing investor interest in the company’s long-term secular opportunity. Bull of the Day: Intuitive Surgical (ISRG)
- Positive Sentiment: Analyst note arguing ISRG can capture growth from ambulatory surgery centers as it markets lower-cost da Vinci systems — a potential multi-year revenue driver if adoption accelerates. Ambulatory Surgery Centers: A Long-Term Growth Opportunity for ISRG?
- Neutral Sentiment: A third‑party head-to-head comparison piece references ISRG alongside a smaller rival; useful for context but unlikely to move shares materially by itself. Head-To-Head Analysis: Lombard Medical & Intuitive Surgical
- Negative Sentiment: The FDA has flagged safety concerns related to Intuitive’s surgical stapler product line after reports of injuries and at least one death, urging halts and alternative device use — a major near-term regulatory and reputational risk that can slow sales, trigger recalls, or prompt increased legal exposure. FDA Flags Safety Concern Over Intuitive Surgical Stapler
- Negative Sentiment: Intuitive confirmed problems with stapler reloads and disclosed one reported death tied to the issue — amplifies regulatory scrutiny and potential product liability exposure. Intuitive warns on surgical stapler reloads with one death reported
- Negative Sentiment: Investigative coverage outlines broader operational snags (from cyber incidents to recalls), increasing short-term uncertainty around execution and compliance. From Cyber Criminals to Recalls: Inside Intuitive Surgical’s Newest Snag
- Negative Sentiment: UBS trimmed its price target on ISRG, a signal that some sell‑side investors are re‑rating the stock amid the recent safety/regulatory news — this can weigh on sentiment until clarity is provided. ISRG Price Target Lowered to $550.00 at UBS Group
Wall Street Analyst Weigh In
A number of equities research analysts have commented on ISRG shares. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Argus decreased their target price on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target for the company in a research report on Wednesday, March 11th. UBS Group reduced their price target on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a research note on Tuesday. Finally, BTIG Research restated a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $614.95.
Check Out Our Latest Research Report on Intuitive Surgical
Insider Buying and Selling at Intuitive Surgical
In related news, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares of the company’s stock, valued at $326,673.60. This represents a 16.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 32,943 shares of company stock valued at $17,279,568 in the last quarter. Corporate insiders own 0.70% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Further Reading
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
